February 2017

Recent recent update to ASCO/ONS standards for chemotherapy administration safety include considerations for a safe healthcare environment, treatment planning, patient education, and consent.

An often over-looked side effect with opioids is opioid-induced constipation. Through communication and collaboration, oncology nurses can help to prevent this adverse event, and manage and correct it when it does occur.

Cancer-related pain is among the most common and difficult symptoms patients confront. Assessing and managing it is also challenging for healthcare practitioners, but asking patients the right questions can help.

In a current phase II/III clinical trial for patients with advanced, recurrent, platinum-resistant ovarian cancer, the novel agent fasbretablin tromethamine is combined with bevacizumab (Avastin) and either paclitaxel or pegylated liposomal doxorubicin.

A current clinical trial for patients with non-small cell lung cancer (NSCLC) is evaluating tepotinib, a small molecule that targets an abnormality in the MET gene.

New treatments for this common side effect are making a big difference, and patients should no longer suffer in silence.

Smilow Cancer Hospital at Yale-New Haven took on a program to assess the effectiveness of mindfulness-based stress relief (MBSR) in patients with cancer.

Two nurse navigators report on the importance of equitable access to care, regardless of a patient's social connections, socioeconomic status, of philanthropy history.